Piper Keenan J, Karsy Michael, Barton Blair, Rabinowitz Mindy, Rosen Marc R, Nyquist Gurston G, Evans James J, Tjoumakaris Stavropoula, Farrell Christopher J
Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
J Neurol Surg Rep. 2021 Sep 29;82(3):e25-e31. doi: 10.1055/s-0041-1735904. eCollection 2021 Jul.
Pituitary adenomas are a common intracranial pathology with an incidence of 15 to 20% in the population while cerebral aneurysms are less common with a prevalence of 1:50 patients. The incidence of aneurysms in patients with pituitary adenoma has been estimated at 2.3 to 5.4% of patients; however, this remains unclear. Equally, the management of concomitant lesions lacks significant understanding. A case report is presented of a concomitant cerebral aneurysm and pituitary adenoma managed by minimally invasive endovascular and endoscopic methods, respectively. A systematic review of the literature for terms "pituitary adenoma" and "aneurysm" yielded 494 studies that were narrowed to 19 relevant articles. We report a case of a 67-year-old patient with an enlarging pituitary macroadenoma, cavernous carotid aneurysm, and unilateral carotid occlusion. After successful treatment of the aneurysm by a pipeline flow diverter, the pituitary adenoma was surgically resected by an endoscopic transsphenoidal approach. The use of a pipeline flow diverter and endonasal approach was feasible in the treatment of our patient. This is the first report to our knowledge of the use of pipeline flow diversion in the management of a cavernous carotid aneurysm prior to pituitary adenoma treatment.
垂体腺瘤是一种常见的颅内病变,人群发病率为15%至20%,而脑动脉瘤则较少见,患病率为1:50。垂体腺瘤患者中动脉瘤的发病率估计为2.3%至5.4%;然而,这一点仍不明确。同样,对于合并病变的处理也缺乏深入了解。本文报告了一例分别采用微创血管内和内镜方法治疗的合并脑动脉瘤和垂体腺瘤的病例。对“垂体腺瘤”和“动脉瘤”相关文献进行系统回顾,共检索到494项研究,最终筛选出19篇相关文章。我们报告一例67岁患者,患有不断增大的垂体大腺瘤、海绵窦段颈内动脉瘤和单侧颈动脉闭塞。在通过血流导向装置成功治疗动脉瘤后,经鼻内镜手术切除垂体腺瘤。在我们的患者治疗中,使用血流导向装置和经鼻入路是可行的。据我们所知,这是首例在治疗垂体腺瘤之前使用血流导向装置治疗海绵窦段颈内动脉瘤的报告。